Safety of desloratadine syrup in children.

@article{Bloom2004SafetyOD,
  title={Safety of desloratadine syrup in children.},
  author={Melvyn Bloom and Heribert W Staudinger and Jerry Herron},
  journal={Current medical research and opinion},
  year={2004},
  volume={20 12},
  pages={1959-65}
}
BACKGROUND Allergic rhinitis (AR) and acute urticaria are common childhood maladies. Typically, the firstline treatment options for both include non-sedating antihistamines. First-generation antihistamines, such as diphenhydramine and hydroxyzine, although useful, cause sedation. Desloratadine, an oral non-sedating antihistamine, has been shown in multiple studies to be safe and effective in relieving the symptoms of AR and chronic idiopathic urticaria (CIU) in adults and adolescents… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Pediatric urticaria.

Immunology and allergy clinics of North America • 2014

Use of second generation H1 antihistamines in special situations.

Journal of investigational allergology & clinical immunology • 2013
View 1 Excerpt

Antihistamine therapy in allergic rhinitis.

Immunology and allergy clinics of North America • 2011

Chronic autoimmune urticaria in children.

Allergologia et immunopathologia • 2009
View 1 Excerpt

Treatment of chronic urticaria.

Acta dermatovenerologica Croatica : ADC • 2009
View 1 Excerpt

Similar Papers

Loading similar papers…